News Shock as AstraZeneca’s charismatic cancer R&D chief José Bas... AstraZeneca is mourning the loss of one of its top scientists after eminent cancer researcher José Baselga passed away at the age of just 61.
News AZ appoints controversial doctor to lead new oncology unit AstraZeneca has a new and controversial oncology head after the departure of two key leaders led to a management reshuffle.
News United's PAH drug clears phase 3 trial, setting up filings United Therapeutics will file ralinepag as a treatment for pulmonary arterial hypertension later this year, but can it compete in a crowded market?
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.